Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 20 | 0 | 2 | 0 | €106.16 | €116.25 | 9.502% |
| Teva Pharmaceutical Industries Ltd ADR | 20 | 0 | 2 | 0 | €15.90 | €19.37 | 21.826% |
| Sutro Biopharma Inc | 20 | 0 | 2 | 0 | €4.00 | €10.97 | 174.155% |
| Celldex Therapeutics | 19 | 0 | 2 | 0 | €38.20 | €62.17 | 62.747% |
| EyePoint Pharmaceuticals Inc. | 20 | 1 | 2 | 0 | €7.44 | €27.83 | 273.872% |
| Krystal Biotech | 19 | 0 | 3 | 0 | €167.90 | €185.58 | 10.530% |
| TG Therapeutics Inc. | 20 | 1 | 0 | 0 | €21.35 | €31.12 | 45.812% |
| Natural Alternat. | 20 | 1 | 1 | 0 | €5.70 | - | - |
| G1 Therapeutics | 19 | 1 | 0 | 0 | €6.47 | €11.09 | 71.527% |
| Exact Sciences | 18 | 0 | 1 | 0 | €53.25 | €76.01 | 42.749% |
| Akero Therapeutics Inc | 17 | 0 | 0 | 0 | €23.75 | €38.19 | 60.815% |
| Corcept Therapeutics Inc. | 17 | 0 | 0 | 0 | €31.75 | €36.87 | 16.120% |
| Medpace Holdings Inc | 16 | 0 | 0 | 0 | €297.20 | €408.19 | 37.344% |
| Geron Corp. | 16 | 0 | 1 | 0 | €3.94 | €5.54 | 40.505% |
| Esperion Therapeutis.Inc. | 17 | 1 | 3 | 0 | €1.56 | €9.27 | 492.701% |
| Rhythm Pharmaceuticals | 15 | 0 | 0 | 0 | €44.60 | €46.51 | 4.271% |
| Catalyst Pharmaceutical Partners Inc | 15 | 0 | 2 | 0 | €17.57 | €25.69 | 46.248% |
| Alkermes plc | 17 | 2 | 0 | 0 | €24.20 | €35.01 | 44.683% |
| Repligen Corp. | 14 | 0 | 0 | 0 | €130.90 | €180.11 | 37.594% |
| Verastem Inc. | 14 | 0 | 2 | 0 | €2.48 | €16.16 | 551.665% |
| Rigel Pharmaceutical Inc. | 14 | 0 | 1 | 0 | €0.74 | €13.88 | 1776.122% |
| MacroGenics Inc. | 14 | 0 | 3 | 0 | €3.22 | €12.31 | 281.669% |
| Galmed Pharmaceuticals Ltd. | 13 | 0 | 1 | 0 | €3.20 | €68.81 | 2050.156% |
| Prothena Corp. plc | 13 | 0 | 2 | 0 | €18.40 | €78.70 | 327.720% |
| Stoke Therapeutics Inc | 14 | 1 | 0 | 0 | €13.20 | €20.33 | 54.042% |